Clinimetric properties of Oxygen-Enhanced MRI

  • Research type

    Research Study

  • Full title

    Determining the clinimetric properties of structural and functional outputs of oxygen-enhanced magnetic resonance imaging in children and adults with cystic fibrosis (CF) and chronic suppurative lung disease (CSLD)

  • IRAS ID

    294686

  • Contact name

    Jane C Davies

  • Contact email

    j.c.davies@imperial.ac.uk

  • Sponsor organisation

    Imperial College London

  • Duration of Study in the UK

    3 years, 11 months, 30 days

  • Research summary

    Scope: Monitoring people with cystic fibrosis (pwCF) and chronic suppurative lung disease (CSLD) is hampered by the relative insensitivity of current outcome measures (eg. spirometry) to detect subtle changes or an inability to perform frequently (eg. related to the radiation burden of CT scanning).
    OE-MRI is a sensitive test with the potential to provide both regional and global lung structural, plus functional scores, without radiation. In this study, we intend to build on our promising pilot data and establish clinimetric applications of OE-MRI.
    Design: Cross-sectional, cohort, and longitudinal observational study.
    Hypothesis: Functional and structural outputs from OE-MRI lung are feasible and valid outcome measures in people with cystic fibrosis
    Aims
    To determine the clinimetric properties of structural and functional outputs of OE-MRI in children and adults with CF and CSLD, specifically:
    1. How stable are repeated tests; do the values change over short periods of time (2-4 weeks)?
    2. How do the values change over longer periods of time, when disease might be progressing (6 months – 2 years)?
    3. How does OE-MRI compare to other lung function tests?
    4. How well do changes in OE-MRI reflect periods of ill-health (exacerbations) and recovery?
    5. Intra and inter-rater agreement on structural MRI scores
    Study Outcomes
    Primary outcome: Variability of OE-MRI (OE outputs and structural scores) in healthy controls (HCs; short term) and clinically stable pwCF (short and longer term)
    Secondary outcomes:
    • Relationships between structural and functional components of OE-MRI
    • Relationships between both the above and other measures of lung function, spirometry and MBW
    • Change in OE-MRI outputs during periods of pulmonary exacerbation
    • Intra and inter-rater agreement for structural MRI scores
    Exploratory outcomes:
    • Impact on the above of baseline clinical features including sex, treatment with highly-effective CFTR modulator therapy (HEMT), infection status, age, nutritional parameters.

    Study duration: 4 years (to allow long term follow-up of patients).

  • REC name

    London - Brighton & Sussex Research Ethics Committee

  • REC reference

    21/PR/0807

  • Date of REC Opinion

    16 Sep 2021

  • REC opinion

    Further Information Favourable Opinion